XBIO Xenetic Biosciences, Inc.

Xenetic Biosciences Inc is a clinical-stage biopharmaceutical company focused on the discovery, research and development of next-generation biologic drugs and novel orphan oncology therapeutics.

$0.76  -0.04 (-5.13%)
As of 07/01/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  04/17/2014
Outstanding shares:  14,316,596
Average volume:  32,640
Market cap:   $11,469,025
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -1.85
PB ratio:   0.60
PS ratio:   15.89
Return on equity:   -34.83%
Net income %:   -816.64%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy